InsiderTrades

Form 4 for TEAD Teads Holding Co.

Accepted 2021-07-29 00:00:00 ET · period of report 2021-07-27 · accession 0001104659-21-097647 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2021-07-29 2021-07-27 TEAD Sela Yossi Dir, Former 10% Owner C - Cnv Deriv $0.00 +4.38M 4.92M +815% $0
DMI 2021-07-29 2021-07-27 TEAD Sela Yossi Dir, Former 10% Owner C - Cnv Deriv $0.00 -4.35M 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-27 C A 4,383,637 $0.00 4,921,763 I See footnote — — (F3) The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. (F2) The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. (F1) The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds.
2 Derivative Series A Preferred Stock 2021-07-27 C D 1,667,090 $0.00 0 I See footnote — · — to — 1,667,090 Common Stock (F3) The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. (F2) The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. (F1) The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds.
3 Derivative Series B Preferred Stock 2021-07-27 C D 1,531,301 $0.00 0 I See footnote — · — to — 1,531,301 Common Stock (F3) The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. (F2) The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. (F1) The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds.
4 Derivative Series C Preferred Stock 2021-07-27 C D 935,247 $0.00 0 I See footnote — · — to — 935,247 Common Stock (F3) The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. (F2) The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. (F1) The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds.
5 Derivative Series F Preferred Stock 2021-07-27 C D 219,244 $0.00 0 I See footnote — · — to — 249,999 Common Stock (F3) The shares of Series A, Series B, Series C and Series F Preferred Stock previously reported by the reporting person converted to Common Stock on July 27, 2021 at the ratios specified in the company's Eleventh Amended and Restated Certificate of Incorporation, which is included as Exhibit 3.3 to the company's Registration Statement on Form S-1, as amended (File No. 333-257525), in connection with the consummation of the company's initial public offering. (F2) The reporting person, through his position, relationship and/or affiliation with the Gemini Entities, may have shared voting and investment power with respect to the shares beneficially owned by the Gemini Funds. As such, the reporting person may be deemed to have or share beneficial ownership of the shares beneficially owned by the Gemini Funds. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. (F1) The shares are held directly by Gemini Israel IV L.P. ("Gemini LP"), Gemini Israel IV (Annex Fund) L.P. ("Gemini LP Annex"), Gemini Partners Investors IV L.P. ("Gemini Partners") and Gemini Partners Investors IV (Annex Fund) L.P. ("Gemini Partners Annex," and together with Gemini LP, Gemini LP Annex and Gemini Partners, the "Gemini Funds"). Gemini Israel Funds Ltd. is the general partner and/or controlling partner of each of the Gemini Funds.